These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 34756279)
21. [Design of the ORCA module in the OCEAN study : Evaluation of SD-OCT results in daily routine practice]. Heimes B; Schick T; Brinkmann CK; Wiedon A; Haegele B; Kirchhof B; Holz FG; Pauleikhoff D; Ziemssen F; Liakopoulos S; Spital G; Schmitz-Valckenberg S Ophthalmologe; 2016 Jul; 113(7):570-80. PubMed ID: 26868827 [TBL] [Abstract][Full Text] [Related]
22. A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders. Cehofski LJ; Honoré B; Vorum H Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452939 [TBL] [Abstract][Full Text] [Related]
23. Saudi Arabia Guidelines for diabetic macular edema: A consensus of the Saudi Retina Group. AlQahtani AS; Hazzazi MA; Waheeb SA; Semidey VA; Semidey VA; Elgendy HK; Alkhars WI; Abouammoh MA; Al-Dhibi H Saudi Med J; 2021 Feb; 42(2):131-145. PubMed ID: 33563731 [TBL] [Abstract][Full Text] [Related]
24. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months. Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ Retina; 2009; 29(10):1396-403. PubMed ID: 19898177 [TBL] [Abstract][Full Text] [Related]
25. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Virgili G; Menchini F; Casazza G; Hogg R; Das RR; Wang X; Michelessi M Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008081. PubMed ID: 25564068 [TBL] [Abstract][Full Text] [Related]
26. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421 [TBL] [Abstract][Full Text] [Related]
27. Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements. Taban M; Sharma S; Williams DR; Waheed N; Kaiser PK Ophthalmology; 2009 May; 116(5):964-70. PubMed ID: 19410954 [TBL] [Abstract][Full Text] [Related]
28. SAFETY AND FEASIBILITY OF A NOVEL 25-GAUGE BIODEGRADABLE IMPLANT OF DEXAMETHASONE FOR TREATMENT OF MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION: A PHASE I CLINICAL TRIAL. Cunha RB; Siqueira RC; Messias A; Scott IU; Fialho SL; Cunha-Junior ADS; Jorge R Retin Cases Brief Rep; 2018 Winter; 12(1):50-58. PubMed ID: 27632583 [TBL] [Abstract][Full Text] [Related]
30. Evolution of intravitreal therapy for retinal and macular disorders. Panos GD J Int Med Res; 2020 Jan; 48(1):300060518771411. PubMed ID: 29726284 [No Abstract] [Full Text] [Related]
31. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion. Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569 [TBL] [Abstract][Full Text] [Related]
32. Retinal function determined by flicker ERGs before and soon after intravitreal injection of anti-VEGF agents. Terauchi G; Shinoda K; Sakai H; Kawashima M; Matsumoto CS; Mizota A; Miyake Y BMC Ophthalmol; 2019 Jun; 19(1):129. PubMed ID: 31208350 [TBL] [Abstract][Full Text] [Related]
33. Influence of macular oedema on the measurement of macular pigment optical density. Thiele S; Rauscher FG; Wiedemann P; Dawczynski J Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):455-65. PubMed ID: 26100452 [TBL] [Abstract][Full Text] [Related]
36. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months. Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ Retina; 2010; 30(7):1002-11. PubMed ID: 20616679 [TBL] [Abstract][Full Text] [Related]
37. Update on the Use of Anti-VEGF Intravitreal Therapies for Retinal Vein Occlusions. Jiang Y; Mieler WF Asia Pac J Ophthalmol (Phila); 2017; 6(6):546-553. PubMed ID: 29204993 [TBL] [Abstract][Full Text] [Related]
38. Monitoring ocular drug therapy by analysis of aqueous samples. Campochiaro PA; Choy DF; Do DV; Hafiz G; Shah SM; Nguyen QD; Rubio R; Arron JR Ophthalmology; 2009 Nov; 116(11):2158-64. PubMed ID: 19700195 [TBL] [Abstract][Full Text] [Related]